Lung organ model and construction method and application thereof

By constructing and exposed to environmental radiation, the shortcomings of animal models in the existing technology in low-dose radiation research are solved, and effective simulation and research on adverse effects on organisms are achieved, providing an efficient research framework .

CN118956730APending Publication Date: 2024-11-15CENT SOUTH UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411209802.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-30
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing animal models have low throughput, high cost, labor-intensive and ethical problems in toxicological research, and it is difficult to effectively simulate the effects of long-term exposure to low doses of environmental radiation on organisms.

Method used

By extracting and pretreating mouse lung organoid tissues, subculture, using specific composition PneumaCultAll culture medium for subculture, constructing lung organoid models, and conducting exposure studies under environmental radiation conditions, simulating low-dose radiation on cell reciprocity. Effects and effects of microenvironment dynamics.

Benefits of technology

The constructed lung organoid model has a longer growth period and is suitable for long-term exposure studies. It can effectively simulate the adverse effects of low-dose radiation on organisms, such as affecting lipid metabolism and calcium ion release, resulting in oxidative stress, providing a The value framework explores the adverse effects of environmental radiation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118956730A_ABST
    Figure CN118956730A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of bioengineering and environmental radiation, in particular to a lung organ model and a construction method and application thereof. The lung organ model is constructed by the construction method. The construction method comprises the following steps: extracting mouse lung organ tissues, and pre-treating to obtain in-vitro mouse lung organs; and carrying out subculture on the isolated mouse lung organ to obtain the lung organ model. The application is the application of the lung organ model in the aspect of environmental radiation. The in-vitro lung organ model constructed by the method has a longer growth period, and is suitable for exposure research under environmental radiation for a long time, so that the simulation of cell interaction and microenvironment dynamics after low-dose radiation is enhanced, and the adverse effect of low-dose environmental radiation on organisms is conveniently explored.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of bioengineering and environmental radiation technology, and in particular to a lung organoid model and a construction method and application thereof. Background Art

[0002] Environmental radiation comes from a variety of sources, including radiation from naturally occurring radioactive substances and radiation from human activities, including cosmic radiation, radiation from naturally occurring radioactive substances in the soil, radiation from nuclear power plants, and medical radiation. Epidemiological studies have shown that environmental radiation may increase the risk of childhood cancer, including leukemia and central nervous system tumors. Environmental radiation may also have health effects, including developmental abnormalities and reproductive problems. Longitudinal studies have shown that long-term exposure to low-dose radiation may impair the health of radiation workers through mechanisms related to taurine metabolism. Studies have shown that low-dose whole-body gamma rays (0.1Gy, 0.5Gy, 1.0Gy, and 2.0Gy) adversely affect the hematopoiesis, reproduction, and splenic lymphocytes of mice.

[0003] Although animal models are considered the gold standard for toxicology studies, in vivo experiments are low-throughput, high-cost, labor-intensive, time-consuming, and accompanied by ethical issues. Guided by the 3R principle (replacement, reduction, and improvement of animal use), the development and enhancement of in vitro models has become increasingly important. Unlike two-dimensional (2D) systems, three-dimensional (3D) systems accurately represent the physiological microenvironment and cellular interactions observed in vivo. These 3D systems enable embryonic and adult mammalian stem cells to exhibit their inherent self-organization capabilities and form organoids that closely mimic the structural and functional characteristics of various organs, including kidneys, lungs, intestines, brains, and retina. Therefore, organoid technology provides a valuable framework for simulating organ development and evaluating toxicological effects in controlled environments. Among them, lung organoids have a longer growth period and are suitable for long-term exposure studies under environmental radiation, thereby enhancing the simulation of cell interactions and microenvironment dynamics after low-dose radiation. Therefore, the present invention provides a lung organoid model and its construction method and application for exploring the adverse effects of environmental radiation on organisms. Summary of the invention

[0004] The purpose of the present invention is to provide a lung organoid model and a construction method and application thereof. The specific technical scheme is as follows:

[0005] In a first aspect, the present invention provides a method for constructing a lung organoid model, comprising:

[0006] Step S1, extracting mouse lung organoid tissue, and obtaining in vitro mouse lung organoids after pretreatment;

[0007] Step S2: subculture the isolated mouse lung organoids to obtain a lung organoid model.

[0008] Optionally, in step S1, the pretreatment includes digesting mouse lung organoid tissue with mouse lung organoid primary tissue digestion fluid, and obtaining in vitro mouse lung organoids after filtration, centrifugation, resuspension, plating and culturing.

[0009] Optionally, in step S2, the subculture uses an organoid subculture preservation medium.

[0010] Optionally, the culture medium used in the organoid passaging and preservation medium is PneumaCultAll culture medium.

[0011] Optionally, the PneumaCultAll culture medium contains the following components: 0.4-0.55 μg / mL hydrocortisone solution, 100 U / mL penicillin solution, 100 μg / mL streptomycin solution, 1-10 μg / mL heparin and 10-50 ng / mL EGF.

[0012] In a second aspect, the present invention provides a lung organoid model obtained by using the lung organoid model construction method.

[0013] In a third aspect, the present invention provides an application of the lung organoid model in environmental radiation.

[0014] Optionally, the environmental radiation includes radiation generated by naturally existing radioactive substances and radiation generated by human activities.

[0015] Optionally, the radiation dose is less than or equal to 2 Gy.

[0016] Optionally, the radiation dose is less than or equal to 0.01 Gy.

[0017] The application of the technical solution of the present invention has at least the following beneficial effects:

[0018] (1) The present invention provides a method for constructing a lung organoid model, which can construct an in vitro lung organoid model with a longer growth period and is suitable for long-term exposure research under environmental radiation, thereby enhancing the simulation of cell interactions and microenvironment dynamics after low-dose radiation, and facilitating the exploration of the adverse effects of low-dose environmental radiation on organisms.

[0019] (2) The organoid culture preservation medium used in the subculture in step S2 of the present invention is specifically a PneumaCultAll culture medium containing specific components and concentrations, which can ensure that a lung organoid model is obtained after subculture.

[0020] (3) The present invention uses the lung organoid model in the context of environmental radiation to demonstrate that low-dose radiation affects lipid metabolism, which can have adverse effects on the organism. For example, increased lipid metabolites can lead to the production of lipid peroxides and ferroptosis. In addition, low-dose radiation can promote calcium ion release and upregulate the cyclooxygenase p450 pathway, which can easily lead to calcium ion overload, causing oxidative stress and adverse effects on the organism.

[0021] In addition to the above-described purposes, features and advantages, the present invention has other purposes, features and advantages. The present invention will be further described in detail with reference to the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] The drawings constituting a part of this application are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute an improper limitation of the present invention. In the drawings:

[0023] Figure 1 is a volcano plot of the metabolic markers of the 0.01 Gy experimental group compared with the 0 Gy experimental group in the metabolomics detection of the embodiment;

[0024] Figure 2 is a volcano plot of the metabolic markers of the 0.05 Gy experimental group compared with the 0 Gy experimental group in the metabolomics detection of the embodiment;

[0025] Figure 3 is a volcano plot of the metabolic markers of the 2Gy experimental group compared with the 0Gy experimental group in the metabolomics detection of the embodiment;

[0026] Figure 4 1. It is a Z-Score diagram of differential metabolites between the 0.01Gy experimental group and the 0Gy experimental group in the metabolomics detection of the embodiment;

[0027] Figure 5 is a circular graph showing the classification and percentage of differential metabolites between the 0.01 Gy experimental group and the 0 Gy experimental group in the metabolomics test of the embodiment;

[0028] Figure 6 is a circular graph showing the classification and percentage of differential metabolites between the 0.05 Gy experimental group and the 0 Gy experimental group in the metabolomics test of the embodiment;

[0029] Figure 7 is a circular graph showing the classification and percentage of differential metabolites between the 2 Gy experimental group and the 0 Gy experimental group in the metabolomics test of the embodiment;

[0030] Figure 8 for Figure 5-Figure 7 Hierarchical clustering diagram of all differential metabolites in;

[0031] Fig. 9 for Figure 5-Figure 7 KEGG heat map of all differential metabolites in;

[0032] Fig.10 for Figure 5-Figure 7 Correlation plot of all differential metabolites in ;

[0033] Fig.11 This is a comparison chart of the palmitoleoylcarnitine content in the 0.01Gy experimental group, the 0.05Gy experimental group and the 2Gy experimental group compared with the 0Gy experimental group;

[0034] Fig.12 It is a volcano plot of all genes in differential expression analysis of the 0.01 Gy experimental group compared with the 0 Gy experimental group in transcriptomics detection in the embodiment;

[0035] Fig.13 is a bubble chart of GO enrichment differences in up-regulated genes and down-regulated genes in the 0.01 Gy experimental group compared with the 0 Gy experimental group in transcriptomics detection in the embodiment;

[0036] Fig.14 is a bubble scatter plot of GO enrichment in up-regulated genes and down-regulated genes in the 0.01 Gy experimental group compared with the 0 Gy experimental group in transcriptomics detection;

[0037] Fig.15 is a line graph of the enrichment scores of positive regulation of chelated calcium ions released into the cytoplasm in the 0.01 Gy experimental group compared with the 0 Gy experimental group in the transcriptomic detection of the embodiment;

[0038] Fig.16 is a line graph of the enrichment scores of the cyclooxygenase p450 pathway in the 0.01 Gy experimental group compared with the 0 Gy experimental group in the transcriptomic detection of the embodiment;

[0039] Fig.17 is a line graph of the enrichment scores of the voltage-gated calcium channel complexes of the 0.01 Gy experimental group compared with the 0 Gy experimental group in the transcriptomics detection of the embodiment;

[0040] Fig.18 is a KEGG hierarchical histogram of differential expression between the 0.01 Gy experimental group and the 0 Gy experimental group in transcriptomics detection in the embodiment;

[0041] Fig.19 It is the ROS detection level of 0Gy experimental group, 0.01Gy experimental group, 0.05Gy experimental group and 2Gy experimental group in ROS detection in the embodiment (green fluorescence represents ROS detected using DCFH-DA, blue fluorescence represents cell nucleus; Merge represents the combined graph of 488nm and Hoechst);

[0042] Fig. 20 Yes Fig.19 Normalized results of ROS detection levels in (n=3, n represents the number of selected fields of view). DETAILED DESCRIPTION

[0043] The following will be combined with the accompanying drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field belong to the scope of protection of the present invention.

[0044] Example:

[0045] (I) A method for constructing a lung organoid model, comprising:

[0046] Step S1, extracting mouse lung organoid tissue, and obtaining in vitro mouse lung organoids after pretreatment;

[0047] Step S2: subculture the isolated mouse lung organoids to obtain a lung organoid model.

[0048] Step S1 is specifically as follows:

[0049] S1.1. Select 4-week-old C57BL / 6 mice, anesthetize them with pentobarbital and kill them, and collect mouse lung organoid tissues.

[0050] S1.2. Place the mouse lung organoid tissue in a 100 mm culture dish filled with tissue preservation fluid and quickly transfer it to a clean clean bench for subsequent operations.

[0051] S1.3. Prepare multiple 100 mm culture dishes and add mouse lung organoid culture buffer pre-cooled to 4°C for later use.

[0052] S1.4. Wash the mouse lung organoid tissue three times with mouse lung organoid culture buffer, and cut the mouse lung organoid tissue into small pieces with a volume of about 1 to 3 mm using a scalpel and tweezers. 3 of lung tissue.

[0053] S1.5. Use 2 mL of mouse lung organoid primary tissue digestion solution to digest the lung tissue blocks, and shake and digest at room temperature for 30 minutes to obtain lung tissue digestion solution.

[0054] S1.6. Add three times the volume of mouse lung organoid culture buffer to the lung tissue digestion solution to stop digestion.

[0055] S1.7. Filter through a 100 μm pore size mesh, collect the filtrate, and put it into a centrifuge tube; centrifuge the centrifuge tube at a centrifugal force of 300 g (centrifugal force refers to the force exerted on an object when it rotates, expressed here in multiples of g (gravitational acceleration)) for 5 minutes, remove the supernatant, add mouse lung organoid culture buffer, remix evenly, and centrifuge.

[0056] S1.8. Place the centrifuge tube on ice to keep it low temperature, add 320 μL Matrigel (matrigel) and resuspend to form a matrix gel mixture.

[0057] S1.9. Take a 24-well culture plate, add 40 μL of the matrix gel mixture to each of the middle 8 wells for plating, and add 1 mL of PBS to the surrounding wells to prevent drying (operate on ice).

[0058] S1.10. Place the plate in a 37°C incubator for 20 minutes to allow the matrix gel mixture to solidify. Add 500 μL of mouse lung organoid culture medium (Absin, avs9541) to each well of the culture plate, and then place it in a 37°C, 5% CO2 incubator for culture. Replace the culture medium with fresh mouse lung organoid culture medium every 2 days. After 21 days of culture, subculture the mouse lung organoids.

[0059] Step S2 is specifically as follows:

[0060] Step S2.1, place the mouse lung organoids after 21 days of culture in a clean bench, discard the culture medium; add 1 mL of ice-cold organoid passage storage solution to each well and incubate for 3 minutes;

[0061] Among them, the culture medium used for the organoid passaging and preservation medium is PneumaCultAll culture medium (Chinese name is human bronchial cell air-liquid interface culture medium), which contains the following components: 0.48μg / mL hydrocortisone solution, 100U / mL penicillin solution, 100μg / mL streptomycin solution, 4μg / mL heparin and 20ng / mL EGF (Chinese name is epidermal growth factor).

[0062] Step S2.2: Use a 1 mL pipette to blow out the matrix gel mixture after incubation.

[0063] Step S2.3: Collect the organoid culture medium containing the matrix gel mixture into a pre-cooled 15 mL centrifuge tube and centrifuge at 300 g for 5 minutes, remove the supernatant, and carefully remove the Matrigel.

[0064] Step S2.4, add 640 μL Matrigel and remix the organoid formation matrix gel mixture.

[0065] Step S2.5, take 2 24-well culture plates, add 40 μL of the matrix gel mixture to each of the middle 8 wells for plating, and add 1 mL of PBS to the surrounding wells to prevent drying (operate on ice); perform 4 subcultures; after 4 subcultures, 16 24-well culture plates of lung organoid models are obtained, and the middle 8 wells on each culture plate contain lung organoid models.

[0066] 2. Application of lung organoid models in environmental radiation

[0067] The lung organoid model obtained after 4 subcultures was subjected to radiation therapy (i.e., radiation generated by human activities) in order to explore the level of adverse effects of environmental radiation on organisms.

[0068] The specific applications are as follows:

[0069] (1) The lung organoid models in 16 24-well culture plates after four subcultures were cultured for another ten days at 37° C. and 5% CO 2 , and the mouse lung organoid culture medium was replaced every two days.

[0070] (2) On the eleventh day of culture, the culture medium of mouse lung organoids was replaced once; then, the 16 24-well culture plates containing lung organoid models were equally divided into four groups (i.e., each group consisted of four 24-well culture plates containing lung organoid models) and transferred to Cobalt 60 (Beijing Institute of Radiological Medicine) for radiotherapy, with radiation doses of 0 Gy, 0.01 Gy, 0.05 Gy and 2 Gy, respectively, marked as 0 Gy experimental group (i.e., Group A), 0.01 Gy experimental group (i.e., Group B), 0.05 Gy experimental group (i.e., Group C) and 2 Gy experimental group (i.e., Group D); after the completion of radiation, the surface of each 24-well culture plate was sprayed with 75% alcohol and transferred to a 37°C, 5% CO2 incubator for continued culture. Among them, a radiation dose of 0.01Gy (i.e., 10mSv) is used to simulate the radiation dose in a general environment for one year; a radiation dose of 0.05Gy (i.e., 50mSv) is used to simulate the radiation dose received by radiation-related staff in hospitals or patients who have undergone multiple CT scans from the environment in one year; and a radiation dose of 2Gy is used to simulate the radiation dose received by humans from the environment in a high-radiation area throughout their lives. In this embodiment, 0.05Gy and 2Gy are used to irradiate the lung organoid model to further verify the correctness of the results obtained under 0.01Gy radiation.

[0071] (3) The culture medium of mouse lung organoids was replaced 48 hours and 96 hours after irradiation.

[0072] (4) Lung organoid models were collected 120 hours after irradiation for omics and ROS detection.

[0073] Omics testing includes metabolomics testing and transcriptomics testing.

[0074] The metabolomics detection method is as follows:

[0075] Three samples were taken from each of the 0 Gy experimental group (i.e., group A), 0.01 Gy experimental group (i.e., group B), 0.05 Gy experimental group (i.e., group C), and 2 Gy experimental group (i.e., group D) for metabolomics detection; each sample was a lung organoid model in 4 wells of a 24-well culture plate. The selected samples were placed on a clean workbench, the mouse lung organoid culture medium was discarded, and 1 mL of ice-cold organoid passage preservation solution was added to each well and incubated for 3 minutes. A 1 mL pipette was used to disperse the matrix gel mixture. The organoid passage preservation solution containing the matrix gel mixture was collected into a pre-cooled 15 mL centrifuge tube, centrifuged at a centrifugal force of 300 g for 5 minutes, and the supernatant was removed; then, 3 mL of ice-cold PBS was added and incubated on ice for 3 minutes. After incubation, centrifuged at 300 g for 5 minutes, the supernatant was removed, and the matrix gel was carefully removed. After marking each sample with a serial number, it was quickly frozen using liquid nitrogen. Finally, each sample was placed in dry ice and mailed to Shanghai Biotree Biotechnology Co., Ltd. for non-targeted metabolomics testing.

[0076] The transcriptomic detection method is as follows:

[0077] Three samples were taken from each of the 0 Gy experimental group (i.e., group A), 0.01 Gy experimental group (i.e., group B), 0.05 Gy experimental group (i.e., group C), and 2 Gy experimental group (i.e., group D) for metabolomics detection; each sample was a lung organoid model in 4 wells of a 24-well culture plate. The selected samples were placed on a clean workbench, the mouse lung organoid culture medium was discarded, and 1 mL of ice-cold organoid passage preservation solution was added to each well and incubated for 3 minutes. A 1 mL pipette was used to disperse the matrix gel mixture. The organoid passage preservation solution containing the matrix gel mixture was collected into a pre-cooled 15 mL centrifuge tube, centrifuged at a centrifugal force of 300 g for 5 minutes, and the supernatant was removed; then, 3 mL of ice-cold PBS was added and incubated on ice for 3 minutes. After incubation, centrifuged at 300 g for 5 minutes, the supernatant was removed, and the matrix gel was carefully removed. After marking each sample with a serial number, it was quickly frozen using liquid nitrogen. Finally, each sample was placed in dry ice and mailed to Shanghai Baiqu Biotechnology Co., Ltd. for transcriptomic testing.

[0078] Phenotypic testing, i.e. detection of ROS in lung organoid models

[0079] Take a 15mL centrifuge tube and prepare the ROS staining working solution (by volume ratio, DCFH-DA (Beyotime, S0033M): Hoechst 33342: PBS solution = 1:1:998). Take 3 samples from each of the 0Gy experimental group (i.e., group A), 0.01Gy experimental group (i.e., group B), 0.05Gy experimental group (i.e., group C) and 2Gy experimental group (i.e., group D) for ROS detection; wherein each sample is a lung organoid model in 1 well of a 24-well culture plate. Remove the lung organoid culture medium from each selected sample, and then take 500μL ROS staining working solution and add it to the well containing the lung organoid to be measured. Transfer to a 37°C, 5% CO2 incubator and incubate for 45 minutes. After the incubation, remove the ROS staining working solution and add 500μL PBS solution to ensure that the matrix gel mixture is moist. The cells were then transferred to a confocal microscope for photography and observation, and the results were quantified using ImageJ software.

[0080] 3. Data Analysis

[0081] GraphPad Prism 8 (GraphPad Software, Inc.) was used for statistical analysis. All data except metabolomics and transcriptomics were analyzed by one-way analysis of variance (ANOVA) combined with multiple comparison tests. Different letters (a, b, c, and d) represent significant differences, where P < 0.05 was considered statistically significant. Metabolomics and transcriptomics were analyzed using the methods provided by Biotree Biotech. The results are reported as mean ± SEM or SD.

[0082] See also Figure 1-Figure 11 The metabolomics test results shown in the figure show that the percentages of differential metabolites of lipid and lipid-like molecules fluctuate greatly with changes in radiation dose, which indicates that environmental radiation can affect lipid metabolism and may cause adverse effects on organisms. For example, the increase in lipid metabolites can lead to the production of lipid peroxides and the occurrence of ferroptosis.

[0083] Specifically, in the metabolomics test, a total of 25,512 metabolite markers were identified and screened from the metabolites of samples from group A to group D; Figure 1-Figure 3 The screening results were visualized in the form of a volcano plot; compared with the 0 Gy experimental group, 290, 284 and 492 metabolites were significantly up-regulated in the 0.01 Gy experimental group, 0.05 Gy experimental group and 2 Gy experimental group, and 150, 605 and 310 metabolites were significantly down-regulated, respectively. The significantly up-regulated and significantly down-regulated metabolites were all differential metabolites.

[0084] Figure 4The Z-Score diagram of differential metabolites, with the horizontal axis representing the Z-Score value and the vertical axis representing the differential metabolites, and points of different colors representing different sample groups; Z-Score is used to standardize the differential metabolites in different samples by calculating the Z-Score value; Figure 4 It can be seen that the differential metabolites of group A are basically concentrated on the left side of the value 0, while the differential metabolites of group B are basically concentrated on the right side of the value 0, which shows that both group A and group B samples have high homogeneity, which is conducive to improving the accuracy of subsequent analysis results.

[0085] Figure 5-Figure 7 The circular graphs respectively show the classification and percentage of differential metabolites in the 0.01Gy experimental group, the 0.05Gy experimental group and the 2Gy experimental group compared with the 0Gy experimental group; wherein different colors in the circular graphs represent different classifications of differential metabolites, and the percentage represents the percentage of the corresponding differential metabolites in the experimental group compared with the 0Gy group. Figure 5-Figure 7 It can be seen that the percentage of differential metabolites of lipid and lipid-like molecules fluctuates greatly with the change of radiation dose; Figure 5 Among the differential metabolites of the 0.01 Gy experimental group, 14.81% of the differential metabolites were lipids and lipid molecules; Figure 7 In the 2 Gy experimental group shown, 28.77% of the differential metabolites were lipids and lipid-like molecules.

[0086] Combination Figure 8 The results of hierarchical clustering analysis of differential metabolites are shown. Fig. 9 KEGG heatmap of differential metabolites is shown as well Fig.10 The results of the differential metabolite correlation analysis showed that in the case of 0.01Gy radiation in the experimental group, the metabolites in the glycerophospholipid metabolic pathway increased significantly. Therefore, some lipid substances were screened out from the metabolomics test results for analysis, and the results are shown in Fig.11 As shown, compared with the 0Gy experimental group, there was no significant difference in the content of palmitoleoylcarnitine under the 0.01Gy experimental group, but the content of palmitoleoylcarnitine under the 2Gy experimental group was significantly increased; this result shows that environmental radiation affects the lipid metabolism process. It is worth noting that in the 0.01Gy experimental group and the 0Gy experimental group, by Fig. 9The KEGG heat map analysis of the differential metabolites shown found that radiation in the 0.01Gy experimental group can affect the lipid metabolism of lung organoids, and the increase in lipid metabolites is closely related to the production of lipid peroxides and the occurrence of ferroptosis. Lipid peroxidation refers to an oxidation reaction caused by free radicals attacking unsaturated fatty acids in cells. This process is particularly important when the levels of free radicals and peroxides in the organism increase. With the increase in lipid metabolites, excessive intermediate metabolites are produced, which can become targets of free radical attack, resulting in increased formation of lipid peroxides. In addition to significant changes in lipid metabolic pathways, metabolic pathways related to energy supply such as galactose metabolism, fructose and mannose metabolism also changed significantly in the 2Gy experimental group compared with the 0Gy experimental group. This suggests that it may be related to changes in mitochondrial function. This shows that metabolomics detection can sensitively analyze differences in biological metabolism caused by environmental radiation.

[0087] See also Figure 12-Figure 17 The transcriptomic detection results shown in the figure show that radiation in the 0.01Gy experimental group promotes the release of calcium ions from lung organoids and upregulates the cyclooxygenase p450 pathway, which can easily lead to calcium ion overload, causing oxidative stress and adverse effects on the organism.

[0088] Specifically, Fig.12 The volcano plot of all genes in the differential expression analysis between the 0.01Gy experimental group and the 0Gy experimental group. Fig.12 The results showed that compared with the 0 Gy experimental group, 19 genes were upregulated and 6 genes were downregulated in the 0.01 Gy experimental group.

[0089] Fig.13 Bubble chart showing the GO enrichment differences between up-regulated genes and down-regulated genes in the 0.01Gy and 0Gy experimental groups; Fig.14 It is a bubble scatter plot of GO enrichment in up-regulated genes compared with down-regulated genes in the 0.01Gy experimental group and the 0Gy experimental group; Fig.13 and Fig.14 It showed that radiation in the 0.01Gy experimental group mainly affected the calcium ion binding of lung organoids.

[0090] Further, combined with Figure 15-17 It can be seen that compared with the 0Gy experimental group, the positive regulation of chelated calcium ions released into the cytoplasm, the cyclooxygenase p450 pathway and the voltage-gated calcium channel complex in the 0.01Gy experimental group were significantly upregulated. This indicates that 0.01Gy radiation can promote calcium ion release and upregulate the cyclooxygenase p450 pathway, which can easily lead to calcium ion overload, causing oxidative stress and adverse effects on the organism.

[0091] See also Fig.18, which showed that there was expression of transcripts related to Glycerolipid Metabolism in transcriptomic detection, confirming that environmental radiation affects the lipid metabolism process.

[0092] See also Figure 19-20 The ROS detection results shown in the figure indicate that compared with the 0 Gy experimental group, the reactive oxygen content in the lung organoids of the 0.01 Gy experimental group, the 0.05 Gy experimental group and the 2 Gy experimental group increased significantly, that is, the ROS levels increased significantly, and showed a dose-dependent trend, which indicates that the radiation dose is positively correlated with the reactive oxygen content produced, and the increased reactive oxygen content will lead to oxidative stress, which will have adverse effects on the organism.

[0093] about Figure 1-Figure 20 The Chinese definitions of some horizontal axes, vertical axes and English phrases are shown in Table 1.

[0094] Table 1 Figure 1-Figure 20 Chinese meanings of some horizontal and vertical coordinates and English phrases in

[0095]

[0096]

[0097]

[0098]

[0099] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A method for constructing a lung organoid model, characterized in that: include: Step S1, extracting mouse lung organoid tissue, and obtaining in vitro mouse lung organoids after pretreatment; Step S2: subculture the isolated mouse lung organoids to obtain a lung organoid model.

2. The method for constructing a lung organoid model according to claim 1, characterized in that: In the step S1, the pretreatment includes digesting the mouse lung organoid tissue with mouse lung organoid primary tissue digestion fluid, and obtaining the in vitro mouse lung organoid after filtering, centrifugation, resuspension, plating and culturing.

3. The method for constructing a lung organoid model according to claim 1, characterized in that: In the step S2, the subculture uses an organoid subculture preservation solution.

4. The method for constructing a lung organoid model according to claim 3, characterized in that: The culture medium used in the organoid passage preservation solution is PneumaCultAll culture medium.

5. The method for constructing a lung organoid model according to claim 4, characterized in that: The PneumaCultAll medium contains the following components: 0.4-0.55 μg / mL hydrocortisone solution, 100 U / mL penicillin solution, 100 μg / mL streptomycin solution, 1-10 μg / mL heparin and 10-50 ng / mL EGF.

6. A lung organoid model, characterized in that: The method for constructing a lung organoid model is used to obtain the lung organoid model.

7. Use of the lung organoid model as described in claim 6 in environmental radiation.

8. The use according to claim 7, characterized in that: The environmental radiation includes radiation generated by naturally existing radioactive substances and radiation generated by human activities.

9. The use according to claim 8, characterized in that: The radiation dose is less than or equal to 2 Gy.

10. The use according to claim 8, characterized in that: The radiation dose is less than or equal to 0.01 Gy.